Parametric Portfolio Associates LLC Purchases 8,831 Shares of Orthofix International N.V. (OFIX)

Parametric Portfolio Associates LLC boosted its position in Orthofix International N.V. (NASDAQ:OFIX) by 18.0% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 57,936 shares of the medical device company’s stock after buying an additional 8,831 shares during the quarter. Parametric Portfolio Associates LLC owned approximately 0.32% of Orthofix International N.V. worth $2,693,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently made changes to their positions in OFIX. UBS Asset Management Americas Inc. acquired a new stake in Orthofix International N.V. in the 1st quarter valued at approximately $229,000. American International Group Inc. raised its position in Orthofix International N.V. by 7.1% in the 1st quarter. American International Group Inc. now owns 10,783 shares of the medical device company’s stock valued at $411,000 after buying an additional 717 shares during the last quarter. OppenheimerFunds Inc. acquired a new stake in Orthofix International N.V. in the 1st quarter valued at approximately $305,000. Principal Financial Group Inc. acquired a new stake in Orthofix International N.V. in the 1st quarter valued at approximately $5,359,000. Finally, Teachers Advisors LLC raised its position in Orthofix International N.V. by 676.2% in the 1st quarter. Teachers Advisors LLC now owns 276,340 shares of the medical device company’s stock valued at $10,542,000 after buying an additional 240,740 shares during the last quarter. 93.80% of the stock is currently owned by institutional investors and hedge funds.

In other news, CEO Brad Mason sold 2,733 shares of Orthofix International N.V. stock in a transaction that occurred on Monday, August 21st. The stock was sold at an average price of $48.10, for a total transaction of $131,457.30. Following the completion of the transaction, the chief executive officer now directly owns 188,053 shares in the company, valued at approximately $9,045,349.30. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Rice Doug sold 7,353 shares of Orthofix International N.V. stock in a transaction that occurred on Monday, September 11th. The stock was sold at an average price of $49.46, for a total value of $363,679.38. Following the transaction, the chief financial officer now owns 44,743 shares of the company’s stock, valued at $2,212,988.78. The disclosure for this sale can be found here. Insiders have sold a total of 23,406 shares of company stock worth $1,138,531 in the last ninety days. Insiders own 5.60% of the company’s stock.

OFIX has been the topic of a number of recent research reports. TheStreet raised Orthofix International N.V. from a “c+” rating to a “b-” rating in a research report on Tuesday, August 8th. BidaskClub raised Orthofix International N.V. from a “hold” rating to a “buy” rating in a research report on Thursday, August 17th. BTIG Research set a $56.00 target price on Orthofix International N.V. and gave the company a “buy” rating in a research report on Monday, October 30th. Zacks Investment Research lowered Orthofix International N.V. from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, October 11th. Finally, Jefferies Group LLC reaffirmed a “buy” rating and set a $55.00 price target (up previously from $50.00) on shares of Orthofix International N.V. in a research report on Thursday, August 10th. Seven equities research analysts have rated the stock with a buy rating, The company currently has a consensus rating of “Buy” and an average price target of $54.42.

Orthofix International N.V. (OFIX) opened at $51.89 on Friday. The firm has a market capitalization of $942.84, a P/E ratio of 33.92, a price-to-earnings-growth ratio of 2.61 and a beta of 0.15. Orthofix International N.V. has a 1 year low of $32.51 and a 1 year high of $54.33.

Orthofix International N.V. (NASDAQ:OFIX) last posted its quarterly earnings results on Monday, October 30th. The medical device company reported $0.42 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.41 by $0.01. The firm had revenue of $105.30 million for the quarter, compared to analyst estimates of $100.67 million. Orthofix International N.V. had a return on equity of 10.26% and a net margin of 0.33%. The business’s quarterly revenue was up 6.9% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.36 EPS. equities research analysts predict that Orthofix International N.V. will post 1.61 earnings per share for the current year.

WARNING: “Parametric Portfolio Associates LLC Purchases 8,831 Shares of Orthofix International N.V. (OFIX)” was originally reported by Community Financial News and is the sole property of of Community Financial News. If you are reading this article on another website, it was illegally stolen and reposted in violation of United States & international copyright & trademark law. The correct version of this article can be read at https://www.com-unik.info/2017/11/05/parametric-portfolio-associates-llc-purchases-8831-shares-of-orthofix-international-n-v-ofix.html.

Orthofix International N.V. Profile

Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim.

Want to see what other hedge funds are holding OFIX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Orthofix International N.V. (NASDAQ:OFIX).

Institutional Ownership by Quarter for Orthofix International N.V. (NASDAQ:OFIX)

What are top analysts saying about Orthofix International N.V.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Orthofix International N.V. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit